Premium
INTERIM ANALYSIS OF PHASE IIIB MAGNIFY STUDY OF INDUCTION R 2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON‐HODGKIN LYMPHOMA
Author(s) -
Sharman J.,
Coleman M.,
Yacoub A.,
Melear J.,
Fanning S.,
Kolibaba K.,
Lansigan F.,
Reynolds C.,
Foon K.,
Li J.,
Llorente M.,
Rummel M.,
Andorsky D.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.76_2629
Subject(s) - medicine , lenalidomide , rituximab , clinical endpoint , interim analysis , refractory (planetary science) , phases of clinical research , follicular lymphoma , lymphoma , oncology , randomization , gastroenterology , clinical trial , surgery , multiple myeloma , physics , astrobiology